Hostname: page-component-7479d7b7d-68ccn Total loading time: 0 Render date: 2024-07-12T19:05:43.118Z Has data issue: false hasContentIssue false
  • English
  • Français

Interferon-gamma in suppurative otitis media: significance of otorrhoea type and disease outcome

Published online by Cambridge University Press:  29 July 2009

A O Lasisi ,
O Olayemi ,
O G Arinola  and
S A Omilabu
A O Lasisi*
Affiliation:
Department of Otorhinolaryngology, College of Medicine, University of Ibadan, Nigeria
O Olayemi
Affiliation:
Department of Obstetrics and Gynaecology (Statistics Section), College of Medicine, University of Ibadan, Nigeria
O G Arinola
Affiliation:
Department of Immunology and Chemical Pathology, College of Medicine, University of Ibadan, Nigeria
S A Omilabu
Affiliation:
Department of Microbiology, University of Lagos, Nigeria
*
Address for correspondence: Dr O A Lasisi, Senior Lecturer, Department of Otorhinolaryngology, Faculty of Clinical Sciences, College of Medicine, PO Box 22040, University of Ibadan, Ibadan, Nigeria. E-mail: akeemlasisi@gmail.com
Get access Rights & Permissions [Opens in a new window]

Abstract

Background:

Interferon-γ has been reported to have an immunoregulatory role in otitis media with effusion. However, such a role remains to be determined in acute suppurative otitis media.

Aim:

To determine the levels of interferon-γ in middle-ear secretion in children with acute suppurative otitis media, and to determine the significance of interferon-γ to the nature of otorrhoea and the outcome of otitis media.

Settings and design:

Prospective, longitudinal follow up of patients selected from community and tertiary health centres.

Methods:

We selected children with acute suppurative otitis media, diagnosed as otorrhoea of less than three months' duration. Middle-ear secretions were collected by pipetting and stored at −80°C. Interferon-γ was assayed using enzyme-linked immunosorbent assay. The patients were treated and followed up for nine to 12 months, to separate those with resolved acute suppurative otitis media from those with chronic suppurative otitis media.

Result:

The study initially included 358 cases of acute suppurative otitis media. Nine-month follow up was achieved in 304 patients (85 per cent). Of these patients, acute suppurative otitis media resolved in 187 (61 per cent), while chronic suppurative otitis media was evident in 117 (39 per cent). The children with completed follow up comprised 173 boys and 131 girls, aged between four months and nine years (mean age 6.6 years; standard deviation 1.32). These children had purulent otorrhoea in 171 cases (56 per cent) and mucoid otorrhoea in 133 cases (44 per cent). The children's middle-ear secretion interferon-γ concentrations ranged from 12 to 126 pg/ml. The mean middle-ear secretion interferon-γ concentration was 27.2 pg/ml (standard deviation 8.8) in patients whose acute suppurative otitis media resolved, and 73.1 pg/ml (standard deviation 9.5) in those progressing to chronic suppurative otitis media. In children with purulent otitis media, the mean middle-ear secretion interferon-γ concentration was 43.5 pg/ml (standard deviation 15.6); in those with mucoid otitis media, it was 74.3 pg/ml (standard deviation 19.1). Univariate analysis revealed significant differences in middle-ear secretion interferon-γ concentration, comparing resolved acute suppurative otitis media and chronic suppurative otitis media cases (p = 0.00), and comparing purulent and mucoid otitis media cases (p = 0.00). Pearson correlation testing revealed significant inverse correlation between interferon-γ concentration and middle-ear secretion immunoglobulin G concentration (p = 0.01), immunoglobulin E concentration (p = 0.03) and immunoglobulin A concentration (p = 0.00).

Conclusion:

A high concentration of interferon-γ in middle-ear secretions promotes chronicity of suppurative otitis media. Further research in this area may lead to the development of agents which assist the control of suppurative otitis media chronicity.

Keywords

Interferon GammaOtitis Media
Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 123 , Issue 10 , October 2009 , pp. 1103 - 1107
Copyright
Copyright © JLO (1984) Limited 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Ealick, SE, Cook, WJ, Vijay-Kumar, S, Carson, M, Nagabhushan, TL, Trotta, PP et al. Three-dimensional structure of recombinant human interferon-gamma. Science 1991;252:698–702CrossRefGoogle ScholarPubMed
2Schroder, K, Hertzog, PJ, Ravasi, T, Hume, DA. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 2004;75:163–89CrossRefGoogle ScholarPubMed
3Abbas, AK, Murphy, KM, Sher, A. Functional diversity of helper T lymphocytes. Nature 1997;383:787–93Google Scholar
4Carter, LL, Dutton, RW. Type 1 and type 2: a fundamental dichotomy for all T-cell subsets. Curr Opin Immunol 1996;8:336–42CrossRefGoogle ScholarPubMed
5Fresno, M, Kopf, M, Rivas, L. Cytokines and infectious diseases. Immunol Today 1997;18:56–8Google Scholar
6Zinkernagel, RF, Hengartner, H. Antiviral immunity. Immunol Today 1997;18:258–60CrossRefGoogle ScholarPubMed
7Morikawa, K, Zhang, J, Nonaka, M, Morikawa, S. Modulatory effect of macrolide antibiotics on the Th1- and Th2-type cytokine production. Int J Antimicrob Agents 2002;19:53–9Google Scholar
8Fischer, BM, Rochelle, LG, Voynow, JA, Akley, NJ, Adler, KB. Tumor necrosis factor-a stimulates mucin secretion and cyclic GMP production by guinea pig tracheal epithelial cells in vitro. Am J Resp Cell Mol Biol 1999;20:413–22Google Scholar
9Lasisi, OA, Arinola, OG, Bakare, RA. Serum and middle ear immunoglobulins in suppurative otitis media. ORL J Otolaryngol Relat Spec 2008;70:389–92CrossRefGoogle ScholarPubMed
10Lasisi, OA, Olaniyan, FA, Muibi, SA, Azeez, AI, Idowu, KG, Lasisi, JT et al. Clinical and demographic risk factors associated with chronic supppurative otitis media. Int J Paed Otorhinolaryngol 2007;71:1549–54Google Scholar
11Lasisi, AO. Comparative analysis of middle ear immune response and micronutrient level between mucoid and purulent otitis media. J Otolaryngol 2008, in pressGoogle Scholar
12Chen, S, Liang, X, Zheng, Y, Liu, W, Liu, X, Long, H et al. The significance of IFN-gamma measurement in middle ear effusion of secretory otitis media [in Chinese]. Lin Chuang Er Bi Yan Hou Ke Za Zhi 2005;19:590–2Google ScholarPubMed
13Yellon, RF, Doyle, WJ, Whiteside, TL, Diven, WF, March, AR, Fireman, P. Cytokines, immunoglobulins, and bacterial pathogens in middle ear effusions. Arch Otolaryngol Head Neck Surg 1995;121:865–9CrossRefGoogle ScholarPubMed
14Himi, T, Suzuki, T, Kodama, H, Takezawa, H, Kataura, A. Immunologic characteristics of cytokines in otitis media with effusion. Ann Otol Rhinol Laryngol Suppl 1992;157:21–5Google Scholar
15Maxwell, K, Leonard, G, Kreutzer, DL. Cytokine expression in otitis media with effusion. Tumor necrosis factor soluble receptor. Arch Otolaryngol Head Neck Surg 1997;123:984–8CrossRefGoogle ScholarPubMed
16Yellon, RF, Leonard, G, Marucha, PT, Craven, R, Carpenter, RJ, Lehmann, WB et al. Characteristics of cytokines present in middle ear effusions. Laryngoscope 1991;101:165–9CrossRefGoogle Scholar
17Nassif, PS, Simpson, SQ, Izzo, AA, Nicklaus, PJ. Interleukin 8 concentration predicts the neutrophil count in middle ear effusion. Laryngoscope 1997;107:1223–7Google Scholar
18Hotomi, M, Samukawa, T, Yamanaka, N. Inter-leukin 8 in otitis media with effusion. Acta Otolaryngol (Stockh) 1994;114:406–9CrossRefGoogle Scholar
19Lasisi, OA, Arinola, OG, Olayemi, O. Role of elevated immunoglobulin E levels in suppurative otitis media. Ann Tr Paed 2008;28:123–7Google ScholarPubMed
20Storgaard, M, Larsen, K, Blegvad, S, Nodgaard, H, Ovesen, T, Andersen, PL et al. Interleukin 8 and chemotactic activity of middle ear effusions. J Infect Dis 1997;175:474–7Google Scholar
21FitzGerald, JE, Green, GG, Stafford, FW, Birchall, JP, Pearson, JP. Characterisation of human middle ear mucus glycoprotein in chronic secretory otitis media (CSOM). Clin Chim Acta 1987;169:281–97CrossRefGoogle ScholarPubMed